Inmune Stock News

LA JOLLA, Calif., March 11, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), an immunology company developing treatments that harness the patient’s innate immune system.

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and...

INmune Bio, Inc., an immunology company developing treatments that harness the patient’s innate immune system to fight disease, today announced that management will present at the 32nd Annual Roth C

INmune Bio, Inc., an immunotherapy company developing therapies that reprogram the patient’s innate immune system to treat disease, today announced that it will release financial results for its 201

Whether it's unpredictable weather or the appearance of new pests and diseases, farming remains as challenging as ever. To help farmers minimize risk and maximize potential return on investment despit

INmune Bio (NASDAQ:INMB) and BIO-TECHNE (NASDAQ:TECH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional owne

INmune Bio, Inc. (INMB), an immunology company developing treatments that reprogram the patient’s innate immune system to fight disease, today announced that it has been awarded a $500,000 grant fro

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...

INmune Bio, Inc. (INMB), an immunology company developing treatments that harness the patient’s innate immune system to fight disease, announced today the publication of new positive data in the jou

INmune Bio, Inc., an immunology company developing therapies that reprogram the patient’s innate immune system to treat diseases, today announced that it has successfully completed the Phase I tria

LA JOLLA, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) --  INmune Bio, Inc. (INMB), an immunology company developing treatments that harness the patient’s innate immune system to fight disease, announc

INmune Bio’s CEO, Dr. R.J. Tesi, will moderate a panel of experts from neuroscience research, clinical trials, and Alzheimer’s drug development. Lawrence T. Friedhoff, M.D., Ph.D., who is credite

Germany-based global provider of digital payments and commerce solutions Wirecard announced on Thursday it has teamed up with NK department stores to accept Ch